Safely and effectively promoting regeneration or restoration of healthy tissue using novel cell-derived biotherapeutics.
At Noveome, our aim is to induce regeneration or restoration of healthy tissue using ST-266, a solution of biologically active components that is made by culturing our proprietary amnion-derived cells under novel conditions.Learn more »
Our products demonstrate the following unique attributes, which can be applied across a wide range of disease indications to improve patient outcomes.
Speed Impaired Wound Healing
Restores Nerve Function
Strong Safety Profile
Noveome Biotherapeutics, Inc. Publishes Data Demonstrating Anti-inflammatory Activity of ST266 in a Preclinical Model of Optic NeuritisFull Story
Noveome Initiates Phase 2 Clinical Trial of ST266 for the Treatment of Allergic ConjunctivitisFull Story
Noveome Shows Its Work to Future ScientistsFull Story